Skip to content
TrialMatch
Sign up
Recruiting

Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation

Create a profile to match View the full record on ClinicalTrials.gov

About this study

This study assesses cardiovascular injury and cardiac fitness in patients with non-small cell lung cancer that has spread to nearby tissue or lymph nodes (locally advanced) receiving model based personalized chemoradiation. The goal of this study is to learn more about the risk of developing heart disease as a result of chemoradiation treatment for lung cancer. Researchers also want to learn if the risk can be reduced by using a patient's individual risk profile to guide cancer treatment and help protect the heart.

Condition
Locally Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8
Tested
6 Minute Walk Functional Test, Biospecimen Collection, Computed Tomography, Echocardiography, Exercise Cardiac Stress Te...
Sponsor
M.D. Anderson Cancer Center

Who can join

Age
18 years and older
Sex
All sexes
Healthy volunteers
Not accepted

Inclusion 9

  • Minimum age: 18 years
  • Study condition: Locally Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8
  • Patient with histologic diagnosis of non-small cell lung cancer, small cell lung cancer, or limited stage - small cell lung cancer (L-SCLC)
  • The recommended treatment is thoracic radiation therapy combined with concurrent systemic therapy (chemotherapy and/or immunotherapy) with or without neoadjuvant and/or adjuvant systemic therapy (chemotherapy, immunotherapy, targeted therapy)
  • \>/= 18 years of age
  • KPS \>/= 70
  • Willing and able to sign informed consents
  • Willing to perform 6minute walking test
  • Willing to preform required cardiac biomarker test for primary end point assessment.

Exclusion 6

  • Unable or unwilling to give written informed consent
  • Previous history of RT to the thorax overlapping with the current treatment field.
  • Pregnant or breast-feeding
  • Renal failure necessitating dialysis
  • Unwilling to perform protocol tests
  • Contraindication for any protocol tests

Where

1 site, 1 recruiting

M D Anderson Cancer Center

Houston, Texas, United States

Recruiting

Contact

Potential match only. Final eligibility is determined by the study team.